[Baseline characteristics and management of patients less than 45 years of age hospitalized for acute coronary syndromes: results from the nationwide French PREVENIR 1 and PREVENIR 2 studies]

Ann Cardiol Angeiol (Paris). 2002 Jan;51(1):15-9. doi: 10.1016/s0003-3928(01)00058-0.
[Article in French]

Abstract

Of 2,626 patients admitted for acute coronary syndromes and participating in the PREVENIR 1 and 2 registries, 202 (8%) were aged less than 45 years. Younger patients were more often smokers (79% versus 37%), but systemic hypertension and diabetes were less frequent. Reperfusion therapy was more frequently used in the younger patients (63% versus 46%). At hospital discharge, aspirin and angiotensin converting enzyme inhibitors were prescribed as often in younger and older patients. In contrast, beta-blocking agents and statins were used more often in the younger patients. More younger patients participated in a cardiac rehabilitation programme. Left ventricular ejection fraction was less altered in the younger age group and none of the younger patients died between hospital discharge and six months follow-up.

Publication types

  • Comparative Study
  • English Abstract
  • Multicenter Study

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Adult
  • Age Factors
  • Angina, Unstable / mortality
  • Angina, Unstable / prevention & control
  • Angina, Unstable / therapy*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Aspirin / therapeutic use
  • Chi-Square Distribution
  • Diabetes Complications
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Follow-Up Studies
  • France
  • Hospitalization
  • Humans
  • Hypertension / complications
  • Hypolipidemic Agents / therapeutic use
  • Logistic Models
  • Male
  • Multivariate Analysis
  • Myocardial Infarction / mortality
  • Myocardial Infarction / prevention & control
  • Myocardial Infarction / therapy*
  • Platelet Aggregation Inhibitors / therapeutic use
  • Risk Factors
  • Stroke Volume
  • Time Factors

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Fibrinolytic Agents
  • Hypolipidemic Agents
  • Platelet Aggregation Inhibitors
  • Aspirin